A phase I study of docetaxel (Taxotere), carboplatin, and gemcitabine (DoCaGem) as first-line therapy for patients with high-risk epithelial tumors of mullerian origin
Phase of Trial: Phase I
Latest Information Update: 25 Jun 2013
At a glance
- Drugs Docetaxel (Primary) ; Gemcitabine (Primary) ; Carboplatin
- Indications Endometrial cancer; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 13 Oct 2005 New trial record.